Claire Rychlewski is an Editor at Axios Pro. She specializes in health and wellness, supply chain and logistics, and employee benefits, focusing on topics such as logistics technology, consumer health, and workplace health and safety. Claire's insights have been featured in Syncron, Axios, Industry Today Media, and MSN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Claire Rychlewski's coverage focuses on business, tech, health, healthcare & pharmaceutical industries. She appears to prioritize articles that include press releases and private sector announcements. Her article titles mostly revolve around mergers and acquisitions in the healthcare industry.
If you are looking to pitch to Claire Rychlewski, consider offering insights into recent M&A activities or significant developments within the healthcare, medtech, or telehealth sectors. Additionally, providing data-backed analysis or exclusive access to notable industry figures could be appealing to her given her frequent citations of data in her articles.
Given that there is no specified geographic focus for Claire’s coverage attributes suggest she takes a broad view of these industries with interest in international as well as domestic market movements and trends.
This information evolves through artificial intelligence and human feedback. Improve this profile .
The raise would be primary capital, and part of the fundraise could comprise between $50 million and $100 million from a strategic, per sources.
The clinical trial technology sector has drawn meaningful strategic and sponsor interest.
The process is launching in a crowded market for health comms and marketing businesses.
Linden Capital has hired Jefferies to shop oncology-focused consultancy Aptitude Health, sources tell Axios Pro.
McKesson agreed to acquire pharma services company Precision Medicine Group from Blackstone for about $2.25 billion, it announced Tuesday.
Eli Lilly has moved from buying oral immunology drugs to buying new ways of treating autoimmune disease.
Pixacore, a founder-owned health care marketing agency, has ended its strategic review, CEO Dhaval Parikh tells Axios Pro.
Optum Health's deal with TPG for its WellMed Florida clinics offers a potential playbook for its other provider markets like Texas.
KKR and Neuberger are anchoring health tech company Datavant's roughly $2.1 billion debt recapitalization, Axios Pro has learned.
Private equity sponsors have been slowly rolling up companies in radiopharma, a sector with a still-limited track record of sponsor exits.
